Ketsumeisei by American Institute of Eastern Medicine

Insulin resistance Syndrome
In recent years, related diseases including hyperlipidemia, type II diabetes mellitus, hyperinsulinemia, hypertension, arteriosclerosis, arteriosclerotic cardio- and craniovascular diseases, lipid metabolism disorders and obesity have been grouped under the umbrella term “insulin resistance syndrome.” These diseases have a common pathomechanism. This concept is similar to zheng syndrome in traditional Chinese medicine, which involves pathology, functionality and constitution.

Traditional Chinese Medicine Theory
The “spleen” of traditional Chinese medicine refers to the functional system controlling digestion, absorption and metabolism. The diabetic constitution is attributed to the metabolic and circulatory pathologic condition associated with “spleen vacuity”, stagnant blood, and liver-kidney yin deficiency. The primary pathology is “spleen vacuity,” characterized by metabolic disorder. This leads to microcirculatory disorder (stagnant blood), which leads to inadequate synthesis of bodily substances (e.g., blood-pressure-controlling substances as liver-kidney yin). Type II diabetes is not rapid onset. The diabetic constitution commonly predates the abnormal rise in blood sugar. Onset of diabetes and diabetic complications may be prevented by early correction of the constitution.

Ingredients: Proprietary blend, flat stem milk vetch seed, Chinese wild yam, safflower, milk vetch root, cape jasmine fruit, kudzu vine root, licorice root, Korean ginseng. Contains no artificial colors, flavors or preservatives. No wheat, gluten, soy or talc.

Recommended Use: Recommended as a dietary supplement. Take 1-2 packet(s) per day without food, or as recommended by your healthcare professional. Take immediately after opening.